Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

26 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
A multicenter experience of thrombotic microangiopathies in Turkey: The Turkish Hematology Research and Education Group (ThREG)-TMA01 study.
Tekgündüz E, Yılmaz M, Erkurt MA, Kiki I, Kaya AH, Kaynar L, Alacacioglu I, Cetin G, Ozarslan I, Kuku I, Sincan G, Salim O, Namdaroglu S, Karakus A, Karakus V, Altuntas F, Sari I, Ozet G, Aydogdu I, Okan V, Kaya E, Yildirim R, Yildizhan E, Ozgur G, Ozcebe OI, Payzin B, Akpinar S, Demirkan F. Tekgündüz E, et al. Among authors: namdaroglu s. Transfus Apher Sci. 2018 Feb;57(1):27-30. doi: 10.1016/j.transci.2018.02.012. Epub 2018 Feb 20. Transfus Apher Sci. 2018. PMID: 29503132
Microbial contamination of hematopoietic progenitor cell products.
Namdaroğlu S, Tekgündüz E, Bozdağ SC, Durgun G, Sarıca A, Demiriz IŞ, Koçubaba S, Iskender G, Kayıkçı O, Altuntaş F. Namdaroğlu S, et al. Transfus Apher Sci. 2013 Jun;48(3):403-6. doi: 10.1016/j.transci.2013.04.026. Epub 2013 May 8. Transfus Apher Sci. 2013. PMID: 23664302
Clinical characteristics and therapeutic outcomes of elderly patients with chronic myeloid leukemia: A retrospective multicenter study.
Korkmaz S, Dal MS, Berber I, Sahin DG, Dogu MH, Ayyildiz O, Nizam I, Albayrak M, Esen R, Namdaroglu S, Sencan M, Akay OM, Hacioglu S, Yildirim R, Eser A, Tombak A, Pala C, Ilhan O. Korkmaz S, et al. Among authors: namdaroglu s. Geriatr Gerontol Int. 2015 Jun;15(6):729-35. doi: 10.1111/ggi.12341. Epub 2014 Sep 26. Geriatr Gerontol Int. 2015. PMID: 25257190
Does defibrotide prophylaxis decrease the risk of acute graft versus host disease following allogeneic hematopoietic cell transplantation?
Tekgündüz E, Kaya AH, Bozdağ SC, Koçubaba Ş, Kayıkçı Ö, Namdaroğlu S, Uğur B, Akpınar S, Batgi H, Bekdemir F, Altuntaş F. Tekgündüz E, et al. Among authors: namdaroglu s. Transfus Apher Sci. 2016 Feb;54(1):30-4. doi: 10.1016/j.transci.2016.01.009. Epub 2016 Jan 12. Transfus Apher Sci. 2016. PMID: 26922995
Management of mobilization failure in 2017.
Namdaroglu S, Korkmaz S, Altuntas F. Namdaroglu S, et al. Transfus Apher Sci. 2017 Dec;56(6):836-844. doi: 10.1016/j.transci.2017.11.017. Epub 2017 Nov 8. Transfus Apher Sci. 2017. PMID: 29153350
Biosimilar filgrastim (leucostim®) have similar efficacy in steady-state hematopoietic progenitor cell mobilization compared to original filgrastim (neupogen®) and lenograstim (granocyte®): A retrospective multicenter study.
Kayıkçı Ö, Tekgündüz E, Kaya AH, Göker H, Aslan A, İskender D, Namdaroglu S, Tetik A, Koçubaba Ş, Altuntaş F. Kayıkçı Ö, et al. Among authors: namdaroglu s. Transfus Apher Sci. 2017 Dec;56(6):832-835. doi: 10.1016/j.transci.2017.11.016. Epub 2017 Nov 10. Transfus Apher Sci. 2017. PMID: 29162397
Impact of Guideline-Driven Approach in Follow-Up of Long-Term Complications After Allogeneic Hematopoietic Cell Transplant: Single Center Experience.
Kaya AH, Namdaroğlu S, Kayıkcı Ö, Merdin A, Batgi H, İskender D, Dal MS, Kızıl Çakar M, Tekgunduz E, Altuntas F. Kaya AH, et al. Among authors: namdaroglu s. Exp Clin Transplant. 2020 Jun;18(3):359-367. doi: 10.6002/ect.2018.0007. Epub 2018 Sep 25. Exp Clin Transplant. 2020. PMID: 30251944 Free article.
26 results